Shilpa Gupta, Director of Genitourinary Oncology at the Cleveland Clinic, shared a post on X:
“What a great Day 1 at ASCO GU 2026! Meeting friends and colleagues and learning about latest data in Prostate Cancer.
Key Takeaways:
- PEACE-3: ARPI + radium-223 improves OS in mCRPC.
- BRCA Away: Upfront PARPi + abiraterone > sequential Tx in BRCA mCRPC.
- PSMA addition: Early Lu-PSMA maintains QOL.
- ASCENDE-RT: Better control, GU toxicity Patient selection matters!
Day 2 ASCO GU 2026 oral urothelial ca session starting now!
Very elegant and thoughtful discussion by Dr Tyler Stewart ASCO GU 2026.
1. B-15: EV-P as the new SOC in MIBC, highlights Qs re: no. of cycles and future of bladder preservation.
2. RC48G001: 2nd line DV in mUC- future role of DV in the fifteen landscape?”
Other articles about ASCO on OncoDaily.
